Middle East & South Asia

Neos Therapeutics, a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery technologies, announced the US launch of Cotempla XR-ODT. Commercially available in select markets since September 2017, Cotempla XR-ODT is the first and only methylphenidate extended-release orally disintegrating tablet for…
Bharat Biotech has announced its next generation typhoid vaccine, Typbar-TCV, has demonstrated its safety and efficacy in a high risk human challenge clinical study carried out at Oxford University. The clinical studies produced 87% effectiveness as per the trial results published in Lancet. The study was conducted in 112 adult…
InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the Japan Patent Office. The patent provides additional protection for the use of certain dosage regimens of cobitolimod for treating chronic active ulcerative colitis in patients that…
CARsgen Therapeutics (CARsgen), a global leader in developing chimeric antigen receptor T-cell (CAR-T cell) therapies for solid tumors announced its first-in-class anti-Claudin18.2-CAR-T cell therapy for gastric and pancreatic cancers has entered into phase-I clinical trial and starts patients recruitment at Changhai Hospital of Shanghai, a renowned hospital of global reputation…
Forensic scientists who need to differentiate genetic profiles in forensic DNA mixtures, such as those commonly associated with crime scenes, now have access to a new next-generation sequencing (NGS) STR panel from Thermo Fisher Scientific. The combination of Applied Biosystems Precision ID GlobalFiler NGS STR Panel v2 and Converge Software…
Page 1 of 2

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: